Cognition Therapeutics Presents Proteomic Biomarker Data
NEW YORK, March 28, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX) presented results of a meta-analysis from the first cohort...
Source: globenewswire.com
Stay updated with breaking news from Patients Observed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, March 28, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX) presented results of a meta-analysis from the first cohort...
21.03.2023 - - CEO Participating on Panel Hosted by Alzheimer’s Drug Discovery Foundation -NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) - Cognition Therapeutics, Inc. (NASDAQ: CGTX) will be presenting results of a proteomic biomarker meta-analysis of ... Seite 1